Se espera que el mercado de antígenos bacterianos y virales nativos alcance los 28.801,15 mil dólares en 2027 desde los 17.105,05 mil dólares de 2019; se estima que crecerá a una tasa compuesta anual del 6,8 % entre 2020 y 2027.
Los antígenos nativos se extraen en su forma natural de las fuentes respectivas. A medida que sufren modificaciones habituales in vivo, tras el aislamiento, presentan un gran parecido con la compleja estructura tridimensional que exhiben en el huésped. En el caso de los antígenos proteicos, estas modificaciones pueden incluir alteraciones postraduccionales como la escisión de proteínas precursoras, la formación de enlaces disulfuro y la adición de grupos de bajo peso molecular mediante procesos como la glicosilación o la fosforilación. El mercado mundial de antígenos bacterianos y virales nativos está impulsado por factores como el creciente uso de antígenos microbianos nativos en diagnóstico y terapéutica, y la creciente prevalencia de enfermedades infecciosas. Sin embargo, las limitaciones asociadas con los antígenos nativos, como el alto costo, los bajos niveles de producción de antígenos y las dificultades de ampliación, obstaculizan el crecimiento del mercado. Sin embargo, los mercados emergentes están creando oportunidades de crecimiento para los actores del mercado.
< /p>
Mercados regionales lucrativos para antígenos bacterianos y virales nativos
Perspectivas del mercado
Uso creciente de antígenos microbianos nativos en Diagnóstico y Terapéutica
Los antígenos son las biomoléculas que son capaces de desencadenar una respuesta inmune en el cuerpo huésped mediante la activación de los linfocitos. Los antígenos bacterianos se utilizan en el desarrollo de diversos tipos de anticuerpos en laboratorios de investigación para mejorar el sistema inmunológico. Además, los antígenos bacterianos también se utilizan ampliamente en ensayos de inmunodiagnóstico como ELISA.
La selección de bibliotecas de antígenos nativos ha llevado al desarrollo de potentes anticuerpos de neutralización contra diversas infecciones bacterianas y virales. Los antígenos nativos se extraen en su forma natural de una fuente correspondiente. Existe una gran demanda de una gran cantidad de antígenos nativos, especialmente en el diagnóstico in vitro y la investigación de vacunas. Según diversos estudios científicos, los antígenos recombinantes presentan problemas de solubilidad y agregación. Además, la asociación de antígenos recombinantes con entidades no proteicas también es diferente y, a veces, deficiente en términos de rendimiento en comparación con los antígenos nativos.
Con el reciente brote de COVID-19, las empresas están desarrollando SARS-CoV-2 comercial. antígenos para apoyar la formulación de vacunas, e investigación y desarrollo para fortalecer el diagnóstico y la terapia de enfermedades. En febrero de 2020, Native Antigen Company se convirtió en la primera empresa en proporcionar comercialmente los nuevos antígenos del coronavirus, utilizando el sistema de expresión VirtuE (HEK293) patentado por la empresa. Por lo tanto, el creciente uso de antígenos nativos, que respaldan eficazmente el diagnóstico y la terapéutica de diversas afecciones médicas, impulsa el crecimiento del mercado de antígenos y anticuerpos bacterianos nativos.
Información basada en el tipo de producto
El mercado de antígenos bacterianos y virales nativos, según el tipo de producto, se segmenta en antígenos de clamidia, antígenos de adenovirus, antígenos de borrelia, antígenos de clostridium, antígenos del virus chikungunya y antígenos del virus del dengue. El segmento de antígenos de clamidia tuvo la mayor participación del mercado en 2019, y se prevé que el mercado del mismo crezca al CAGR más alto durante el período previsto. El crecimiento del mercado para este segmento se atribuye a la fácil disponibilidad de estos antígenos, y la mayoría de los actores del mercado ofrecen comercialmente estos antígenos en sus formas nativas. Además, se espera que el uso de antígenos de clamidia en institutos y laboratorios de investigación para el desarrollo de vacunas y pruebas de diagnóstico in vitro (IVD) impulse el crecimiento del mercado para este segmento.
Mercado de antígenos virales y bacterianos nativos, por tecnología– 2018 y 2027
Información basada en el tipo de patógeno
Según el tipo de patógeno, el mercado de antígenos virales y bacterianos nativos se segmenta en inactivados patógeno y patógeno purificado. El segmento de patógenos inactivados tuvo una mayor participación del mercado en 2019 y se estima que registrará una CAGR más alta durante el período de pronóstico.
Información basada en aplicaciones
Según la aplicación, el mercado de antígenos virales y bacterianos nativos se segmenta en ELISA, inmunoensayo, SDS-PAGE, hemaglutinación y pruebas de aglutinación. El segmento ELISA tuvo la mayor participación de mercado en 2019 y se estima que registrará la CAGR más alta durante 2020-2027.
Información basada en el usuario final
Según el usuario final, el mercado de antígenos virales y bacterianos nativos se segmenta en laboratorios y centros de diagnóstico e institutos académicos y de investigación. El segmento de centros y laboratorios de diagnóstico tuvo la mayor participación de mercado en 2019 y se estima que registrará la CAGR más alta de 2020 a 2027.
Perspectivas estratégicas
Los lanzamientos y aprobaciones de productos son las estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos; estas estrategias les ayudan a satisfacer la creciente demanda de los consumidores. La colaboración es una de las principales estrategias adoptadas por las empresas que operan en el mercado de antígenos virales y bacterianos nativos para ampliar su base de clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.
Mercado de antígenos virales y bacterianos nativos: por tipo de producto
- Antígenos de clamidia – Antígenos de adenovirus
- Antígenos de borrelia
- Antígenos del virus chikungunya < li>Antígenos de Clostridium
- Antígenos del virus del dengue
Mercado de antígenos virales y bacterianos nativos - ndash; por tipo de patógeno
- Patógeno inactivado
- Patógeno purificado
Mercado de antígenos virales y bacterianos nativos: por aplicación
- ELISA
- Inmunoensayo
- SDS-PAGE
- Hemaglutinación
- Prueba de aglutinación
Mercado de antígenos virales y bacterianos nativos: por usuario final
- Laboratorios y centros de diagnóstico
- Institutos académicos y de investigación
Mercado de antígenos virales y bacterianos nativos– por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de Asia Pacífico
- Medio Oriente y África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de Oriente Medio y África
- Sur y Centroamérica
- Brasil
- Argentina
- Resto de Sudamérica
< /p>
Perfiles de la empresa
- BIO-RAD LABORATORIES INC.
- Microbix Biosystems
- SERION Immunologics
- Aalto Bio Reagents Ltd
- Enzo Life Sciences Inc.
- Jena Bioscience GmbH
- ROSS SOUTHERN LABORATORIES
- The Native Antigen Company
- Diagnóstico creativo
- TRINA BIOREACTIVES AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Native antigens are extracted in their natural form from an appropriate source. Because they have undergone the usual modifications that would occur in vivo, they bear a very close resemblance when isolated to the complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications can include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation.
Factors such as increasing use of native microbial antigens in diagnostics and therapeutics, and rising prevalence of infectious diseases drive the growth of the market.Moreover, developments in emerging markets is expected to offer lucrative opportunities for the growth of the market.
The native bacterial and viral antigensmarket majorly consists of the players such as BIO-RAD LABORATORIES, INC., Microbix Biosystems, SERION Immunologics, Aalto Bio Reagents Ltd., Enzo Life Sciences, Inc., Jena Bioscience GmbH, ROSS SOUTHERN LABORATORIES, The Native Antigen Company, Creative Diagnostics, and TRINA BIOREACTIVES AG amongst others.
The List of Companies - Native Bacterial and Viral Antigens Market
- BIO-RAD LABORATORIES INC.
- Microbix Biosystems
- SERION Immunologics
- Aalto Bio Reagents Ltd
- Enzo Life Sciences Inc.
- Jena Bioscience GmbH
- ROSS SOUTHERN LABORATORIES
- The Native Antigen Company
- Creative Diagnostics
- TRINA BIOREACTIVES AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)